Mount Sinai International has entered into a 10-year strategic collaboration and co-branding agreement with the Taikang Insurance Group in China to further advance the clinical and management capabilities at Taikang Xianlin Drum Tower Hospital in Nanjing, a city of more than 8 million in eastern China. Areas of focus in the first year of this collaboration include quality and patient safety, IT infrastructure and management, and oncology clinical care delivery.
Among those in the photo above, taken during a recent week-long onsite quality and safety workshop conducted by Mount Sinai International, are three leaders of this effort, starting seventh from left: Brijen Shah, MD, Director of Quality Improvement for the Mount Sinai Health System; Li Zhiping, MD, President, Taikang Xianlin Drum Tower Hospital; and Tao Xu, MD, Medical Director, Mount Sinai International.